Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
29 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsAstellas Announces Approval in Japan for XOSPATAŽ 40 mg Tablets for the Treatment of FLT3mut+ Relapsed or Refractory AML
(WorldNews Japan)

 
 

21 september 2018 08:49:39

 
Astellas Announces Approval in Japan for XOSPATAŽ 40 mg Tablets for the Treatment of FLT3mut+ Relapsed or Refractory AML
(WorldNews Japan)
 
TOKYO, September 21, 2018 -Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., `Astellas` ) today announced that XOSPATAŽ Tablets 40 mg (generic name: gilteritinib), a FLT3 (FMS-like tyrosine kinase 3) inhibitor received manufacturing and marketing...


 
12 viewsCategory: General > Asia > Japan
 
Impact of Heavy Rains in July 2018 on Production, etc. (Loss Occurrence) [PDF format]
(WorldNews Japan)
Drone delivery of newspapers tested in Hokkaido
(WorldNews Japan)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten